Table 8.
Number of pivotal studies (%) | |
---|---|
Appropriate statistical analysis | |
Yes |
48 (44.4%) |
No |
41 (38.0%) |
Don’t know (too few details) |
19 (17.6%) |
Summary statistics at baseline | |
Yes |
71 (65.7%) |
With statistical testing |
7 (6.5%) |
Summary statistics at outcome | |
No |
5 (4.6%) |
Yes, for all endpoints |
44 (40.7%) |
Statistically tested |
14 (13.0%) |
Not statistically tested |
30 (27.8%) |
Yes, partially |
45 (41.7%) |
Statistically tested |
31 (28.7%) |
Not statistically tested |
14 (13.0%) |
Yes, only primary |
14 (13.0%) |
Statistically tested |
10 (9.3%) |
Not statistically tested |
4 (3.7%) |
Intention-to-treat analysis | |
Yes |
74 (68.5%) |
No |
8 (7.4%) |
Not applicable / Not reported |
26 (24.0%) |
Reported with respect to patients lost to follow-up | |
Reasons for loss to follow-up |
70 (64.8%) |
Characteristics |
2 (1.9%) |
Not applicable | 8 (7.4%) |